Inactive Instrument
Alexion Pharmaceuticals, Inc. Share Price
Stocks
ALXN
US0153511094
Pharmaceuticals
| 1 day | +1.70% |
| Manager | Title | Age | Since |
|---|---|---|---|
Marc Dunoyer
CEO | Chief Executive Officer | 73 | - |
Sean Christie
DFI | Director of Finance/CFO | 53 | 31/07/2021 |
Doyle Shane
COO | Chief Operating Officer | - | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 20/07/21 | Issuer sale | Director | 22,758 | 0.0103% | ||
| 20/07/21 | Issuer sale | Chief Operating Officer | 172,582 | 0.0781% | ||
| 20/07/21 | Issuer sale | EVP, Chief Compliance Officer | 141,240 | 0.0639% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.70% | -2.20% | - | - | 40.34B | |
| -2.33% | -2.09% | +50.33% | +162.29% | 1,060B | |
| -0.82% | -2.30% | +62.97% | +61.11% | 619B | |
| -0.73% | -4.98% | +27.22% | +84.46% | 438B | |
| +0.33% | -1.17% | +27.98% | +26.90% | 333B | |
| -0.02% | -2.85% | +25.27% | +44.88% | 282B | |
| -3.89% | -11.22% | +20.78% | +26.07% | 267B | |
| +0.66% | -1.42% | -29.26% | -39.30% | 218B | |
| -0.06% | -2.88% | +20.98% | +61.70% | 196B | |
| -3.72% | -1.10% | +13.35% | +71.53% | 161B | |
| Average | -0.64% | -3.25% | +24.40% | +55.51% | 397.1B | |
| Weighted average by Cap. | -0.54% | -2.96% | +35.28% | +81.27% |
Employees
3,837
Sector
Pharmaceuticals
Choose MarketScreener 
